IN-SIGHT

Specialisation

Glaucoma

Full title

Efficacy and safety assessment of T4032 (unpreserved bimatoprost 0.01%) versus Lumigan 0.01% in ocular hypertensiove or glacomatous patients

Promoter

THEA

Start date

March 2019

Researchers

Main: Dr Elena Arrondo 

Co-Researchers: Dr Sílvia Freixes i Dr Laia Pascual

You may be interested in